Cargando…

Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies

Population-scale expression profiling studies can provide valuable insights into biological and disease-underlying mechanisms. The availability of phenotypic traits is essential for studying clinical effects. Therefore, missing, incomplete, or inaccurate phenotypic information can make analyses chal...

Descripción completa

Detalles Bibliográficos
Autores principales: Niehues, Anna, Bizzarri, Daniele, Reinders, Marcel J.T., Slagboom, P. Eline, van Gool, Alain J., van den Akker, Erik B., ’t Hoen, Peter A.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339202/
https://www.ncbi.nlm.nih.gov/pubmed/35907790
http://dx.doi.org/10.1186/s12864-022-08771-7
_version_ 1784760142759198720
author Niehues, Anna
Bizzarri, Daniele
Reinders, Marcel J.T.
Slagboom, P. Eline
van Gool, Alain J.
van den Akker, Erik B.
’t Hoen, Peter A.C.
author_facet Niehues, Anna
Bizzarri, Daniele
Reinders, Marcel J.T.
Slagboom, P. Eline
van Gool, Alain J.
van den Akker, Erik B.
’t Hoen, Peter A.C.
author_sort Niehues, Anna
collection PubMed
description Population-scale expression profiling studies can provide valuable insights into biological and disease-underlying mechanisms. The availability of phenotypic traits is essential for studying clinical effects. Therefore, missing, incomplete, or inaccurate phenotypic information can make analyses challenging and prevent RNA-seq or other omics data to be reused. A possible solution are predictors that infer clinical or behavioral phenotypic traits from molecular data. While such predictors have been developed based on different omics data types and are being applied in various studies, metabolomics-based surrogates are less commonly used than predictors based on DNA methylation profiles.In this study, we inferred 17 traits, including diabetes status and exposure to lipid medication, using previously trained metabolomic predictors. We evaluated whether these metabolomic surrogates can be used as an alternative to reported information for studying the respective phenotypes using expression profiling data of four population cohorts. For the majority of the 17 traits, the metabolomic surrogates performed similarly to the reported phenotypes in terms of effect sizes, number of significant associations, replication rates, and significantly enriched pathways.The application of metabolomics-derived surrogate outcomes opens new possibilities for reuse of multi-omics data sets. In studies where availability of clinical metadata is limited, missing or incomplete information can be complemented by these surrogates, thereby increasing the size of available data sets. Additionally, the availability of such surrogates could be used to correct for potential biological confounding. In the future, it would be interesting to further investigate the use of molecular predictors across different omics types and cohorts. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at (10.1186/s12864-022-08771-7).
format Online
Article
Text
id pubmed-9339202
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93392022022-08-01 Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies Niehues, Anna Bizzarri, Daniele Reinders, Marcel J.T. Slagboom, P. Eline van Gool, Alain J. van den Akker, Erik B. ’t Hoen, Peter A.C. BMC Genomics Research Population-scale expression profiling studies can provide valuable insights into biological and disease-underlying mechanisms. The availability of phenotypic traits is essential for studying clinical effects. Therefore, missing, incomplete, or inaccurate phenotypic information can make analyses challenging and prevent RNA-seq or other omics data to be reused. A possible solution are predictors that infer clinical or behavioral phenotypic traits from molecular data. While such predictors have been developed based on different omics data types and are being applied in various studies, metabolomics-based surrogates are less commonly used than predictors based on DNA methylation profiles.In this study, we inferred 17 traits, including diabetes status and exposure to lipid medication, using previously trained metabolomic predictors. We evaluated whether these metabolomic surrogates can be used as an alternative to reported information for studying the respective phenotypes using expression profiling data of four population cohorts. For the majority of the 17 traits, the metabolomic surrogates performed similarly to the reported phenotypes in terms of effect sizes, number of significant associations, replication rates, and significantly enriched pathways.The application of metabolomics-derived surrogate outcomes opens new possibilities for reuse of multi-omics data sets. In studies where availability of clinical metadata is limited, missing or incomplete information can be complemented by these surrogates, thereby increasing the size of available data sets. Additionally, the availability of such surrogates could be used to correct for potential biological confounding. In the future, it would be interesting to further investigate the use of molecular predictors across different omics types and cohorts. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at (10.1186/s12864-022-08771-7). BioMed Central 2022-07-31 /pmc/articles/PMC9339202/ /pubmed/35907790 http://dx.doi.org/10.1186/s12864-022-08771-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Niehues, Anna
Bizzarri, Daniele
Reinders, Marcel J.T.
Slagboom, P. Eline
van Gool, Alain J.
van den Akker, Erik B.
’t Hoen, Peter A.C.
Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies
title Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies
title_full Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies
title_fullStr Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies
title_full_unstemmed Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies
title_short Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies
title_sort metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339202/
https://www.ncbi.nlm.nih.gov/pubmed/35907790
http://dx.doi.org/10.1186/s12864-022-08771-7
work_keys_str_mv AT niehuesanna metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies
AT bizzarridaniele metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies
AT reindersmarceljt metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies
AT slagboompeline metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies
AT vangoolalainj metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies
AT vandenakkererikb metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies
AT metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies
AT metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies
AT thoenpeterac metabolomicpredictorsofphenotypictraitscanreplaceandcomplementmeasuredclinicalvariablesinpopulationscaleexpressionprofilingstudies